Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Neurochemistry International|September 1, 1993
Vasoactive intestinal peptide: role of calmodulin and catalytic antibodiesD R BolinAgents and Actions|September 1, 1991
Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activitiesW C Hope, B J Patel, D R BolinBiopolymers|January 1, 1995
Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthmaD R Bolin, J Michalewsky, M A Wasserman, et al.European Journal of Immunology|May 1, 1995
Down-regulation of class II major histocompatibility complex molecules on antigen presenting cells after interaction with helper T cellsD Vidović, F Falcioni, D R Bolin, et al.International Journal of Peptide and Protein Research|February 1, 1993
Structure-activity studies of vasoactive intestinal peptide (VIP): cyclic disulfide analogsD R Bolin, J Cottrell, R Garippa, et al.Scandinavian Journal of Immunology|March 31, 1998
Peptide dependence of major histocompatibility complex class II specific alloreactive responsesD Vidović, J I Toral, D R Bolin, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptorM Xia, S P Sreedharan, D R Bolin, et al.The Journal of Biological Chemistry|April 5, 1991
Structure-activity studies of vasoactive intestinal polypeptideM O'Donnell, R J Garippa, N C O'Neill, et al.International Journal of Peptide and Protein Research|September 1, 1995
Structure-activity studies on the vasoactive intestinal peptide pharmacophore. 1. Analogs of tyrosineD R Bolin, J Cottrell, R Garippa, et al.Drug Design and Discovery|April 1, 1996
Comparison of cyclic and linear analogs of vasoactive intestinal peptideD R Bolin, J Cottrell, R Garippa, et al.Pageof 2